Cargando…
Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization
INTRODUCTION: Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associated with balloon cells (IIb). We present a mult...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050872/ https://www.ncbi.nlm.nih.gov/pubmed/37006485 http://dx.doi.org/10.3389/fneur.2023.1023950 |
_version_ | 1785014732265095168 |
---|---|
author | Assis-Mendonça, Guilherme Rossi Athié, Maria Carolina Pedro Tamanini, João Vitor Gerdulli de Souza, Arethusa Zanetti, Gabriel Gerardini Araújo, Patrícia Aline Oliveira Ribeiro de Aguiar Ghizoni, Enrico Tedeschi, Helder Alvim, Marina Koutsodontis Machado de Almeida, Vanessa Simão de Souza, Welliton Coras, Roland Yasuda, Clarissa Lin Blümcke, Ingmar Vieira, André Schwambach Cendes, Fernando Lopes-Cendes, Iscia Rogerio, Fabio |
author_facet | Assis-Mendonça, Guilherme Rossi Athié, Maria Carolina Pedro Tamanini, João Vitor Gerdulli de Souza, Arethusa Zanetti, Gabriel Gerardini Araújo, Patrícia Aline Oliveira Ribeiro de Aguiar Ghizoni, Enrico Tedeschi, Helder Alvim, Marina Koutsodontis Machado de Almeida, Vanessa Simão de Souza, Welliton Coras, Roland Yasuda, Clarissa Lin Blümcke, Ingmar Vieira, André Schwambach Cendes, Fernando Lopes-Cendes, Iscia Rogerio, Fabio |
author_sort | Assis-Mendonça, Guilherme Rossi |
collection | PubMed |
description | INTRODUCTION: Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associated with balloon cells (IIb). We present a multicentric study to evaluate the transcriptomes of the gray and white matters of surgical FCD type II specimens. We aimed to contribute to pathophysiology and tissue characterization. METHODS: We investigated FCD II (a and b) and control samples by performing RNA-sequencing followed by immunohistochemical validation employing digital analyses. RESULTS: We found 342 and 399 transcripts differentially expressed in the gray matter of IIa and IIb lesions compared to controls, respectively. Cholesterol biosynthesis was among the main enriched cellular pathways in both IIa and IIb gray matter. Particularly, the genes HMGCS1, HMGCR, and SQLE were upregulated in both type II groups. We also found 12 differentially expressed genes when comparing transcriptomes of IIa and IIb lesions. Only 1 transcript (MTRNR2L12) was significantly upregulated in FCD IIa. The white matter in IIa and IIb lesions showed 2 and 24 transcripts differentially expressed, respectively, compared to controls. No enriched cellular pathways were detected. GPNMB, not previously described in FCD samples, was upregulated in IIb compared to IIa and control groups. Upregulations of cholesterol biosynthesis enzymes and GPNMB genes in FCD groups were immunohistochemically validated. Such enzymes were mainly detected in both dysmorphic and normal neurons, whereas GPNMB was observed only in balloon cells. DISCUSSION: Overall, our study contributed to identifying cortical enrichment of cholesterol biosynthesis in FCD type II, which may correspond to a neuroprotective response to seizures. Moreover, specific analyses in either the gray or the white matter revealed upregulations of MTRNR2L12 and GPNMB, which might be potential neuropathological biomarkers of a cortex chronically exposed to seizures and of balloon cells, respectively. |
format | Online Article Text |
id | pubmed-10050872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100508722023-03-30 Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization Assis-Mendonça, Guilherme Rossi Athié, Maria Carolina Pedro Tamanini, João Vitor Gerdulli de Souza, Arethusa Zanetti, Gabriel Gerardini Araújo, Patrícia Aline Oliveira Ribeiro de Aguiar Ghizoni, Enrico Tedeschi, Helder Alvim, Marina Koutsodontis Machado de Almeida, Vanessa Simão de Souza, Welliton Coras, Roland Yasuda, Clarissa Lin Blümcke, Ingmar Vieira, André Schwambach Cendes, Fernando Lopes-Cendes, Iscia Rogerio, Fabio Front Neurol Neurology INTRODUCTION: Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associated with balloon cells (IIb). We present a multicentric study to evaluate the transcriptomes of the gray and white matters of surgical FCD type II specimens. We aimed to contribute to pathophysiology and tissue characterization. METHODS: We investigated FCD II (a and b) and control samples by performing RNA-sequencing followed by immunohistochemical validation employing digital analyses. RESULTS: We found 342 and 399 transcripts differentially expressed in the gray matter of IIa and IIb lesions compared to controls, respectively. Cholesterol biosynthesis was among the main enriched cellular pathways in both IIa and IIb gray matter. Particularly, the genes HMGCS1, HMGCR, and SQLE were upregulated in both type II groups. We also found 12 differentially expressed genes when comparing transcriptomes of IIa and IIb lesions. Only 1 transcript (MTRNR2L12) was significantly upregulated in FCD IIa. The white matter in IIa and IIb lesions showed 2 and 24 transcripts differentially expressed, respectively, compared to controls. No enriched cellular pathways were detected. GPNMB, not previously described in FCD samples, was upregulated in IIb compared to IIa and control groups. Upregulations of cholesterol biosynthesis enzymes and GPNMB genes in FCD groups were immunohistochemically validated. Such enzymes were mainly detected in both dysmorphic and normal neurons, whereas GPNMB was observed only in balloon cells. DISCUSSION: Overall, our study contributed to identifying cortical enrichment of cholesterol biosynthesis in FCD type II, which may correspond to a neuroprotective response to seizures. Moreover, specific analyses in either the gray or the white matter revealed upregulations of MTRNR2L12 and GPNMB, which might be potential neuropathological biomarkers of a cortex chronically exposed to seizures and of balloon cells, respectively. Frontiers Media S.A. 2023-03-15 /pmc/articles/PMC10050872/ /pubmed/37006485 http://dx.doi.org/10.3389/fneur.2023.1023950 Text en Copyright © 2023 Assis-Mendonça, Athié, Tamanini, Souza, Zanetti, Araújo, Ghizoni, Tedeschi, Alvim, Almeida, de Souza, Coras, Yasuda, Blümcke, Vieira, Cendes, Lopes-Cendes and Rogerio. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Assis-Mendonça, Guilherme Rossi Athié, Maria Carolina Pedro Tamanini, João Vitor Gerdulli de Souza, Arethusa Zanetti, Gabriel Gerardini Araújo, Patrícia Aline Oliveira Ribeiro de Aguiar Ghizoni, Enrico Tedeschi, Helder Alvim, Marina Koutsodontis Machado de Almeida, Vanessa Simão de Souza, Welliton Coras, Roland Yasuda, Clarissa Lin Blümcke, Ingmar Vieira, André Schwambach Cendes, Fernando Lopes-Cendes, Iscia Rogerio, Fabio Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title | Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title_full | Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title_fullStr | Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title_full_unstemmed | Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title_short | Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization |
title_sort | transcriptome analyses of the cortex and white matter of focal cortical dysplasia type ii: insights into pathophysiology and tissue characterization |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050872/ https://www.ncbi.nlm.nih.gov/pubmed/37006485 http://dx.doi.org/10.3389/fneur.2023.1023950 |
work_keys_str_mv | AT assismendoncaguilhermerossi transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT athiemariacarolinapedro transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT tamaninijoaovitorgerdulli transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT desouzaarethusa transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT zanettigabrielgerardini transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT araujopatriciaalineoliveiraribeirodeaguiar transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT ghizonienrico transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT tedeschihelder transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT alvimmarinakoutsodontismachado transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT dealmeidavanessasimao transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT desouzawelliton transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT corasroland transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT yasudaclarissalin transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT blumckeingmar transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT vieiraandreschwambach transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT cendesfernando transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT lopescendesiscia transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization AT rogeriofabio transcriptomeanalysesofthecortexandwhitematteroffocalcorticaldysplasiatypeiiinsightsintopathophysiologyandtissuecharacterization |